Camblong Jurgi 4

What Happened

• Jurgi Camblong, Chief Executive Officer of SOPHiA GENETICS SA (SOPH), sold 8,500 shares on May 11, 2026.
• The reported weighted-average price was $5.09 per share, for total proceeds of $43,241. The shares were sold in multiple transactions at prices ranging from $4.72 to $5.49.

Key Details

• Transaction date: May 11, 2026; filing date: May 12, 2026 (filed the next day).
• Sale type/code: S (open-market sale); total shares sold: 8,500; weighted-average price: $5.09; price range: $4.72–$5.49 (multiple trades).
• Shares owned after the transaction: not disclosed in this Form 4 filing.
• Footnotes: F1 indicates the sale was made pursuant to a pre-established Rule 10b5-1 trading plan; F2 notes the weighted-average price and offers to provide a breakdown of shares sold at each price on request.
• Filing timeliness: The Form 4 was filed the calendar day after the transaction and does not appear to be late.

Context

• This was a sale (a routine liquidity event), not a purchase or option exercise. The use of a 10b5-1 plan means the trades were pre-arranged under an established trading plan and are commonly used to avoid timing questions about insider trades.
• The total proceeds (~$43.2K) are modest; as with all insider sales, this single filing should be considered alongside other filings and company/contextual information rather than taken alone as a signal.